MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$75,228K
EPS
-$0.71
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Collaboration revenue
0 17,851* 2,764 11,476
Impairment of long-lived assets
0 -1,927* 3,855 0
Research and development
98,162 87,844* 74,094 78,388
General and administrative
20,357 15,716* 17,336 17,645
Total operating expenses
118,519 101,632* 95,285 96,033
Loss from operations
-84,154 -83,781* -92,521 -84,557
Interest and other income
14,981 10,676* 10,444 8,051
Interest and other expense
61 61* 98 108
Total other income
14,920 10,615* 10,346 7,943
Net loss
-69,234 -73,167* -82,175 -76,614
Unrealized gain on marketable securities
-5,994 947* 1,222 337
Total comprehensive loss
-75,228 -72,221 -80,953 -76,277
Basic EPS
-0.71 -0.843 -0.94 -0.95
Diluted EPS
-0.71 -0.843 -0.94 -0.95
Basic Average Shares
97,534,269 85,722,064 87,300,286 80,449,405
Diluted Average Shares
97,534,269 85,722,064 87,300,286 80,449,405
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$75,228K Interest and other income$14,981K Net loss-$69,234K Unrealized gain onmarketable securities-$5,994K Total other income$14,920K Interest and otherexpense$61K Loss from operations-$84,154K something is missing$34,365K Total operatingexpenses$118,519K Research and development$98,162K General andadministrative$20,357K

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. (KYMR)